Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

Background: The hepatic outcome of hepatitis B surface antigen (HBsAg) positive patients undergoing chemotherapy after withdrawal of pre-emptive lamivudine is unknown. Aims: To examine the occurrence of hepatitis B virus (HBV) reactivation after withdrawal of pre-emptive lamivudine. Methods: Pre-emp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hui, C-K, Cheung, W W W, Au, W-Y, Lie, A K W, Zhang, H-Y, Yueng, Y-H, Wong, B C Y, Leung, N, Kwong, Y-L, Liang, R, Lau, G K K
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2005 by Gut 2005
Assuntos:
Hepatitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774754/
https://ncbi.nlm.nih.gov/pubmed/16000641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.070763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados